SLS
Sellas Life Sciences Group Inc
11.40$
-1.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -60.1% | -60.0% | -100.0% | – | -54.9% | -83.4% | +1,916.0% | -92.0% | – | – | – | |
| – | -64.2% | +17.2% | +40.0% | -87.5% | +45.1% | +0.9% | +74.9% | +70.7% | -19.5% | +12.5% | +25.1% | |
| – | -226.4% | – | – | +17.2% | -56.1% | -77.3% | +205.7% | +416.8% | – | – | – | |
| – | +398.4% | -225.4% | – | -265.0% | – | – | -236.2% | – | -40.7% | -298.7% | – | |
| – | -97.2% | -96.1% | -100.0% | – | – | – | – | – | +22.2% | -100.0% | – | |
| – | – | -110.2% | – | – | – | +0.0% | +0.0% | +0.0% | +22.2% | – | – | |
| – | – | +0.0% | +38.6% | -27.9% | -100.0% | – | – | – | – | – | – | |
| – | +84.2% | -28.3% | -98.6% | +6,498.5% | -37.3% | +94.9% | – | – | – | – | – | |
| – | +121.5% | – | -102.7% | +1,507.0% | – | – | – | – | – | – | – | |
| – | +80.7% | -21.7% | -83.9% | +317.8% | -15.4% | +96.4% | -68.6% | +99.4% | -7.3% | +109.5% | +84.6% | |
| – | – | -291.6% | – | – | – | +1,355.1% | -149.8% | – | – | – | +409.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.